| Literature DB >> 26310812 |
Savita Joglekar1, Peter N Nau2, James J Mezhir1.
Abstract
Sarcopenia is the subclinical loss of skeletal muscle and strength and has been extensively studied in both the cancer and surgical literature. Specifically, sarcopenia has gained significant recognition as an important prognostic factor for both complications and survival in cancer patients. Herein, we review the current literature to date highlighting the specific impact of sarcopenia in patients undergoing oncologic procedures.Entities:
Keywords: adenocarcinoma; complications; sarcopenia; survival
Mesh:
Year: 2015 PMID: 26310812 PMCID: PMC5112759 DOI: 10.1002/jso.24025
Source DB: PubMed Journal: J Surg Oncol ISSN: 0022-4790 Impact factor: 3.454